miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1

Prostate cancer (PCa) is one of the most common types of cancer in men. In the course of the development and progression of this disease, abnormal expression of miR-203 is usually accompanied. However, its rol...

Source: BMC Cancer - October 27, 2020 Category: Cancer & Oncology Authors: Yang Meng, Xiaoyan Hu, Shasha Li, Xinyi Zeng, Lei Qiu, Mingtian Wei, Ziqing Wang and Junhong Han Tags: Research article Source Type: research